Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib

Mise à jour : Il y a 4 ans
Référence : NCT01478373

Femme et Homme

Extrait

The purpose of this study is to evaluate the efficacy and safety of Dovitinib in patients with gastrointestinal stromal tumors refractory and/or intolerant to Imatinib


Critère d'inclusion

  • gastrointestinal stromal tumors


Liens